Search results (21)
« Back to PublicationsMYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.
Lau I-J. et al, (2026), Blood, 147, 2865 - 2878
Menin maintains enhancer-promoter interactions in a leukemia-specific manner
Sharlandjieva V. et al, (2026)
A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment.
Meaker GA. et al, (2025), Blood, 146, 3188 - 3200
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.
Smith AL. et al, (2025), Blood, 146, 2073 - 2087
PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.
Cross JW. et al, (2025), Blood Adv, 9, 4607 - 4613
Iron deficiency causes aspartate-sensitive dysfunction in CD8+ T cells.
Teh MR. et al, (2025), Nat Commun, 16
TRANCERs: Engineering enhancers into autonomous tissue-specific expression cassettes
Barrow Molina E. et al, (2025)
The Fetal Specific Gene LIN288 Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia
Ling RE. et al, (2024), BLOOD, 144, 199 - 200
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
Bueno C. et al, (2023), Blood, 142, 1752 - 1756
Temporal analyses reveal a pivotal role for sense and antisense enhancer RNAs in coordinate immunoglobulin lambda locus activation.
Gao Z. et al, (2023), Nucleic Acids Res, 51, 10344 - 10363
Author Correction: Capture-C: a modular and flexible approach for high-resolution chromosome conformation capture.
Downes DJ. et al, (2023), Nat Protoc, 18
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Crump NT. et al, (2023), Nat Commun, 14
P332: LIN28B: AN IMPORTANT ONCO-FETAL GENE IN INFANT ACUTE LYMPHOBLASTIC LEUKAEMIA
Ling R. et al, (2023), HemaSphere, 7, e5649016 - e5649016